We are pleased to announce that ACTS has joined St. Peter’s Health Partners Medical Associates.
SPHPMA is one of the Capital Region’s largest multi-specialty physician groups with more than 850 physicians and advanced practitioners in more than 100 locations.
To learn more about SPHPMA, click here.
ABOUT US
Albany Cardiothoracic Surgeons is the oldest heart surgery practice dedicated to cardiothoracic surgery in the Capital District. Our history is a 50-year long tradition of working as a coordinated team to provide expert, high quality, compassionate cardiothoracic surgical care. We serve residents in a broad tri-state area, centered in the Capital District of New York.
Albany Cardiothoracic Surgeons is the exclusive provider of cardiac surgery at St. Peters Hospital in Albany, New York. Our services range from the latest techniques of minimally invasive surgery to the most complex and difficult surgery requiring combinations of traditional and advanced techniques. Our surgical results have surpassed both the state and national standards.
Please see our contact information for office locations and directions.
OUR MISSION
- We treat all persons with dignity, hospitality and compassion, calling forth their best human potential.
- We provide comprehensive services that support healthy communities, including quality medical care with holistic approaches to healing body, mind and spirit.
- We care for and strengthen the ministry and all resources entrusted to us.
- We advocate for accessible health care and quality of life for all, especially those who are poor.
- We respond with courage and integrity to needs for services in a rapidly changing health care environment.
LATEST CARDIOLOGY NEWS
(MedPage Today) -- The FDA authorized the Libre Duo 10 Day Continuous Dual Glucose-Ketone Monitoring System for people ages 2 years and older with diabetes, the agency announced Tuesday.
As the first wearable device to track both ketones and glucose...
(MedPage Today) -- In January, Jeff La Marca got a prescription for the popular weight loss drug tirzepatide (Zepbound). But he couldn't afford the $750 monthly price tag.
Then Medicare launched an 18-month pilot program that offers GLP-1 medications...
(MedPage Today) -- FDA 510(k) clearance was given to Tempus ECG-PH, an artificial intelligence (AI) software that interprets ECGs for signs of pulmonary hypertension (PH).
Researchers also developed p-Cal, an AI-based screening tool for pericarditis...
(MedPage Today) -- The FDA cleared the Elecsys pTau217 blood test to identify amyloid-beta pathology associated with Alzheimer's disease in people ages 55 and older with symptoms of cognitive decline, Roche announced Monday.
The test, developed...
(MedPage Today) -- A new study may add fuel to the fire already burning around avacopan (Tavneos), approved in 2021 to treat anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV), which the FDA wants drugmaker Amgen to pull...